{"id":4109,"date":"2010-03-09T07:06:47","date_gmt":"2010-03-09T07:06:47","guid":{"rendered":"http:\/\/cardiophile.org\/?p=4109"},"modified":"2010-03-09T07:06:47","modified_gmt":"2010-03-09T07:06:47","slug":"ncx-inhibitors-na-ca2-exchange-inhibitors-to-limit-ischemic-injury","status":"publish","type":"post","link":"https:\/\/johnsonfrancis.org\/professional\/ncx-inhibitors-na-ca2-exchange-inhibitors-to-limit-ischemic-injury\/","title":{"rendered":"NCX inhibitors (Na+ \/ Ca2+ exchange inhibitors) to limit ischemic injury"},"content":{"rendered":"<h2><span style=\"color: #008000;\">NCX inhibitors (Na+ \/ Ca2+ exchange inhibitors) to limit ischemic injury<\/span><\/h2>\n<p>Elevation of calcium levels in the cells is an important mechanism of ischemic cellular injury and death. Na<sup>+<\/sup> \/ Ca<sup>2+<\/sup> exchanger (NCX) has the main role in elevating calcium levels within the myocardial cells during ischemia and reperfusion. Hence NCX inhibitors have been considered to be potential novel agents for limiting hypoxic cell injury.<\/p>\n<p>Three genes encoding for NCX in the human genome are NCX1, NCX2 and NCX3. NCX1 is present in heart, brain and kidney. NCX2 and NCX3 are seen in brain and skeletal muscle. It is interesting to note that while NCX1 knockout is embryonically lethal, NCX2 knockout increases hippocampal long term potentiation and improves performance on learning and memory tests.<br \/>\nThough homozygous NCX1 knockouts are embryonic lethal, heterozygote NCX1 knockouts are viable. These transgenic mice have reduced NCX protein levels and have lesser rise of calcium levels within the cells after hypoxia and have a reduced susceptibility to ischemic injury.<\/p>\n","protected":false},"excerpt":{"rendered":"<p> NCX inhibitors have been considered to be potential novel agents for limiting hypoxic cell injury<\/p>\n","protected":false},"author":1,"featured_media":37100,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","footnotes":""},"categories":[6],"tags":[],"class_list":["post-4109","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ecg-electrophysiology"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NCX inhibitors to limit ischemic injury<\/title>\n<meta name=\"description\" content=\"NCX inhibitors have been considered to be potential novel agents for limiting hypoxic cell injury\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/johnsonfrancis.org\/professional\/ncx-inhibitors-na-ca2-exchange-inhibitors-to-limit-ischemic-injury\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NCX inhibitors to limit ischemic injury\" \/>\n<meta property=\"og:description\" content=\"NCX inhibitors have been considered to be potential novel agents for limiting hypoxic cell injury\" \/>\n<meta property=\"og:url\" content=\"https:\/\/johnsonfrancis.org\/professional\/ncx-inhibitors-na-ca2-exchange-inhibitors-to-limit-ischemic-injury\/\" \/>\n<meta property=\"og:site_name\" content=\"All About Cardiovascular System and Disorders\" \/>\n<meta property=\"article:published_time\" content=\"2010-03-09T07:06:47+00:00\" \/>\n<meta name=\"author\" content=\"Johnson Francis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Johnson Francis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/ncx-inhibitors-na-ca2-exchange-inhibitors-to-limit-ischemic-injury\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/ncx-inhibitors-na-ca2-exchange-inhibitors-to-limit-ischemic-injury\\\/\"},\"author\":{\"name\":\"Johnson Francis\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"headline\":\"NCX inhibitors (Na+ \\\/ Ca2+ exchange inhibitors) to limit ischemic injury\",\"datePublished\":\"2010-03-09T07:06:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/ncx-inhibitors-na-ca2-exchange-inhibitors-to-limit-ischemic-injury\\\/\"},\"wordCount\":172,\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/ncx-inhibitors-na-ca2-exchange-inhibitors-to-limit-ischemic-injury\\\/#primaryimage\"},\"thumbnailUrl\":\"\",\"articleSection\":[\"ECG \\\/ Electrophysiology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/ncx-inhibitors-na-ca2-exchange-inhibitors-to-limit-ischemic-injury\\\/\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/ncx-inhibitors-na-ca2-exchange-inhibitors-to-limit-ischemic-injury\\\/\",\"name\":\"NCX inhibitors to limit ischemic injury\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/ncx-inhibitors-na-ca2-exchange-inhibitors-to-limit-ischemic-injury\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/ncx-inhibitors-na-ca2-exchange-inhibitors-to-limit-ischemic-injury\\\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2010-03-09T07:06:47+00:00\",\"description\":\"NCX inhibitors have been considered to be potential novel agents for limiting hypoxic cell injury\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/ncx-inhibitors-na-ca2-exchange-inhibitors-to-limit-ischemic-injury\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/ncx-inhibitors-na-ca2-exchange-inhibitors-to-limit-ischemic-injury\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/ncx-inhibitors-na-ca2-exchange-inhibitors-to-limit-ischemic-injury\\\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/ncx-inhibitors-na-ca2-exchange-inhibitors-to-limit-ischemic-injury\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NCX inhibitors (Na+ \\\/ Ca2+ exchange inhibitors) to limit ischemic injury\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\",\"name\":\"All About Cardiovascular System and Disorders\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\",\"name\":\"Johnson Francis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"caption\":\"Johnson Francis\"},\"logo\":{\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\"},\"description\":\"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/author\\\/jf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NCX inhibitors to limit ischemic injury","description":"NCX inhibitors have been considered to be potential novel agents for limiting hypoxic cell injury","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/johnsonfrancis.org\/professional\/ncx-inhibitors-na-ca2-exchange-inhibitors-to-limit-ischemic-injury\/","og_locale":"en_US","og_type":"article","og_title":"NCX inhibitors to limit ischemic injury","og_description":"NCX inhibitors have been considered to be potential novel agents for limiting hypoxic cell injury","og_url":"https:\/\/johnsonfrancis.org\/professional\/ncx-inhibitors-na-ca2-exchange-inhibitors-to-limit-ischemic-injury\/","og_site_name":"All About Cardiovascular System and Disorders","article_published_time":"2010-03-09T07:06:47+00:00","author":"Johnson Francis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Johnson Francis","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/johnsonfrancis.org\/professional\/ncx-inhibitors-na-ca2-exchange-inhibitors-to-limit-ischemic-injury\/#article","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/ncx-inhibitors-na-ca2-exchange-inhibitors-to-limit-ischemic-injury\/"},"author":{"name":"Johnson Francis","@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"headline":"NCX inhibitors (Na+ \/ Ca2+ exchange inhibitors) to limit ischemic injury","datePublished":"2010-03-09T07:06:47+00:00","mainEntityOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/ncx-inhibitors-na-ca2-exchange-inhibitors-to-limit-ischemic-injury\/"},"wordCount":172,"publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/ncx-inhibitors-na-ca2-exchange-inhibitors-to-limit-ischemic-injury\/#primaryimage"},"thumbnailUrl":"","articleSection":["ECG \/ Electrophysiology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/johnsonfrancis.org\/professional\/ncx-inhibitors-na-ca2-exchange-inhibitors-to-limit-ischemic-injury\/","url":"https:\/\/johnsonfrancis.org\/professional\/ncx-inhibitors-na-ca2-exchange-inhibitors-to-limit-ischemic-injury\/","name":"NCX inhibitors to limit ischemic injury","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#website"},"primaryImageOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/ncx-inhibitors-na-ca2-exchange-inhibitors-to-limit-ischemic-injury\/#primaryimage"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/ncx-inhibitors-na-ca2-exchange-inhibitors-to-limit-ischemic-injury\/#primaryimage"},"thumbnailUrl":"","datePublished":"2010-03-09T07:06:47+00:00","description":"NCX inhibitors have been considered to be potential novel agents for limiting hypoxic cell injury","breadcrumb":{"@id":"https:\/\/johnsonfrancis.org\/professional\/ncx-inhibitors-na-ca2-exchange-inhibitors-to-limit-ischemic-injury\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/johnsonfrancis.org\/professional\/ncx-inhibitors-na-ca2-exchange-inhibitors-to-limit-ischemic-injury\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/johnsonfrancis.org\/professional\/ncx-inhibitors-na-ca2-exchange-inhibitors-to-limit-ischemic-injury\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/johnsonfrancis.org\/professional\/ncx-inhibitors-na-ca2-exchange-inhibitors-to-limit-ischemic-injury\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/johnsonfrancis.org\/professional\/"},{"@type":"ListItem","position":2,"name":"NCX inhibitors (Na+ \/ Ca2+ exchange inhibitors) to limit ischemic injury"}]},{"@type":"WebSite","@id":"https:\/\/johnsonfrancis.org\/professional\/#website","url":"https:\/\/johnsonfrancis.org\/professional\/","name":"All About Cardiovascular System and Disorders","description":"","publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/johnsonfrancis.org\/professional\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec","name":"Johnson Francis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","caption":"Johnson Francis"},"logo":{"@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g"},"description":"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal","url":"https:\/\/johnsonfrancis.org\/professional\/author\/jf\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/4109","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/comments?post=4109"}],"version-history":[{"count":0,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/4109\/revisions"}],"wp:attachment":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media?parent=4109"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/categories?post=4109"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/tags?post=4109"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}